No abstract

Background and objective Airway inflammation accompanying exacerbations varies among individuals with some having neutrophilic, while others showing eosinophilic inflammation. This study assessed the cut‐off values of blood eosinophil count for identifying subjects with longer hospital length of stay (LOS) with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). Methods Patients were recruited at presentation to the hospital with an AECOPD. Complete blood picture with differential count was taken on admission. Patients were treated with a standard course of systemic corticosteroid and antibiotic and evaluated at 8 weeks post‐exacerbation for lung function measurement and 6‐min walk. They were followed up in 1 year for any readmissions or mortality. Cut‐off values of eosinophils for assessment of longer LOS were calculated using receiver operating characteristic (ROC) curve analysis. Results A total of 346 patients with admission eosinophil count were included in the analysis (333 (96.2%) were males; mean ± SD age: 74.9 ± 7.8 years; mean forced expiratory volume in 1 s (FEV1): 43.4 ± 16.3% predicted). The median (interquartile range (IQR)) of the absolute peripheral eosinophil count, percent eosinophil count and LOS were 0.11 (0.25) × 109/L, 1 (3) % and 5 (7) days, respectively. Using the median LOS of ≥5 days as the cut‐off, ROC analysis of the cut‐off value of eosinophil count associated with longer LOS was at <2% (area under the curve (AUC): 0.666, P < 0.001) while absolute eosinophil count was at <0.144 × 109/L (AUC: 0.645, P < 0.001). These eosinophil cut‐off values could predict longer LOS independent of age, lung function and previous hospital admissions, but had no association with readmissions for AECOPD and mortality at 12 months. Conclusion An eosinophil value of <0.144 × 109/L on admission or <2% was associated with longer hospital LOS for AECOPD.

The effective doses from these common pediatric CT examinations ranged from 0.7mSv to 3.5mSv and the associated lifetime cancer risks were found to be up to 0.16%, with some organs of higher radiosensitivity including breast, thyroid gland, colon and lungs.

No abstract